A multicentre double‐blind, double‐dummy, randomised study of recombinant human thrombopoietin versus eltrombopag in the treatment of immune thrombocytopenia in Chinese adult patients
| Autor: | Min Xu, Tingting Qin, Ping Yin, Ruibin Huang, Feiyue Zhu, Guolin Yuan, Jingming Guo, Tingting Lv, Jun Qin, Huili Cai, Yu Hu, Heng Mei, Fangmei Qin |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Adult
Male China medicine.medical_specialty Eltrombopag Benzoates Gastroenterology Double blind chemistry.chemical_compound Double-Blind Method Internal medicine medicine Humans Platelet Adverse effect Purpura Thrombocytopenic Idiopathic Adult patients business.industry Recombinant Human Thrombopoietin Hematology Middle Aged Recombinant Proteins Immune thrombocytopenia Discontinuation Hydrazines Thrombopoietin chemistry Pyrazoles Female business |
| Zdroj: | British Journal of Haematology. 195:781-789 |
| ISSN: | 1365-2141 0007-1048 |
| Popis: | We performed a double-blind, double-dummy controlled study to compare the efficacy between recombinant human thrombopoietin (rhTPO) and eltrombopag in rapidly increasing the platelet counts in Chinese patients with immune thrombocytopenia (ITP). A total of 96 patients diagnosed with ITP for ≥6 months who had baseline platelet counts of |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text